|
|
|
Insider
Information: |
Kassberg Thomas Richard |
Relationship: |
|
City: |
Brisbane |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
252,823 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$10,148,315 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
252,823 |
|
|
Total
Value |
$10,148,315 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
10
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
9
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-239.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
InterMune Inc |
ITMN |
Former SVP-Cor.Dev.Com... |
2007-12-28 |
0 |
2006-01-16 |
0 |
Premium* |
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-11 |
252,823 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2019-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
90,968 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
91,675 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
|
2014-12-10 |
4 |
AS |
$40.22 |
$134,053 |
D/D |
(3,333) |
92,472 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
See RemarksOfficer |
|
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
92,850 |
|
- |
|
RARE |
Ultragenyx Pharmaceutical... |
Chief Business Officer & SVP |
|
2014-01-30 |
4 |
B |
$21.00 |
$31,500 |
D/D |
1,500 |
94,350 |
2.74 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
|
2014-11-12 |
4 |
AS |
$41.85 |
$139,486 |
D/D |
(3,333) |
95,805 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
|
2014-10-08 |
4 |
AS |
$53.26 |
$177,516 |
D/D |
(3,333) |
99,138 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2020-10-14 |
4 |
S |
$87.98 |
$23,051 |
D/D |
(262) |
101,478 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2020-05-06 |
4 |
D |
$66.26 |
$16,432 |
D/D |
(248) |
101,675 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2020-06-01 |
4 |
D |
$69.38 |
$24,144 |
D/D |
(348) |
101,740 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2020-04-19 |
4 |
D |
$58.57 |
$14,525 |
D/D |
(248) |
101,923 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2020-03-01 |
4 |
D |
$56.08 |
$115,917 |
D/D |
(2,067) |
102,171 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
|
2014-09-10 |
4 |
AS |
$54.82 |
$182,715 |
D/D |
(3,333) |
102,471 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,434 |
104,109 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
|
2014-09-03 |
4 |
AS |
$55.00 |
$550,000 |
D/D |
(10,000) |
105,804 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2021-05-06 |
4 |
S |
$113.69 |
$41,269 |
D/D |
(363) |
106,818 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2021-03-01 |
4 |
S |
$138.17 |
$631,713 |
D/D |
(4,572) |
107,181 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,136 |
111,614 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
|
2014-09-02 |
4 |
AS |
$52.82 |
$528,200 |
D/D |
(10,000) |
115,804 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
Chief Business Officer & SVP |
|
2014-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
31,454 |
125,804 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2022-03-01 |
4 |
S |
$66.62 |
$158,156 |
D/D |
(2,374) |
213,840 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2021-10-14 |
4 |
S |
$81.14 |
$23,206 |
D/D |
(286) |
216,266 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2021-09-30 |
4 |
OE |
$0.31 |
$34,018 |
D/D |
109,734 |
216,552 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2022-03-11 |
4 |
S |
$67.01 |
$688,930 |
D/D |
(10,281) |
227,559 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
227,840 |
0 |
- |
|
84 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|